Attention Deficit Hyperactivity Disorder Global Market Report 2025

Description

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition marked by persistent inattention, hyperactivity, and impulsivity that disrupt daily functioning. It typically starts in childhood and may continue into adulthood, affecting focus, self-control, and organizational skills. Treatment options include behavioral therapy, medication, and lifestyle changes.

The primary types of ADHD treatment are stimulants and non-stimulants. Stimulants are medications that increase brain activity to improve focus, attention, and impulse control, and are commonly used for managing ADHD. ADHD treatments are categorized by age (children and adults) and gender (male and female). ADHD medications come in various forms, including tablets, capsules, and others, and are distributed through multiple channels such as retail pharmacies, hospital pharmacies, and online pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The attention deficit hyperactivity disorder market research report is one of a series of new reports from The Business Research Company that provides attention deficit hyperactivity disorder market statistics, including the attention deficit hyperactivity disorder industry global market size, regional shares, competitors with the attention deficit hyperactivity disorder market share, detailed attention deficit hyperactivity disorder market segments, market trends, and opportunities, and any further data you may need to thrive in the attention deficit hyperactivity disorder industry. This attention deficit hyperactivity disorder market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The attention deficit hyperactivity disorder market size has grown strongly in recent years. It will grow from $16.29 billion in 2024 to $17.38 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising prevalence of ADHD, growing incidence of ADHD in children, and increasing awareness of ADHD, increasing healthcare expenditure, government initiatives for mental health awareness.

The attention deficit hyperactivity disorder market size is expected to see strong growth in the next few years. It will grow to $22.42 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing pediatric and adult patient populations receiving treatment, advanced healthcare infrastructure, growing adoption of personalized medicine, growing acceptance of mental health issues, and rising use of additives and preservatives in children's diet. Major trends in the forecast period include improvements in technology and innovative treatments, advancements in diagnostic and treatment methods, development of new therapeutic agents, shift towards non-stimulant medications, and advancements in pharmaceutical treatments.

The forecast of 6.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. mental healthcare by increasing the cost of extended-release stimulant medications and digital therapeutic apps sourced from Israel and Canada, thereby reducing treatment adherence and elevating pediatric psychiatry expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing adoption of personalized medicine is expected to drive the growth of the attention deficit hyperactivity disorder (ADHD) market in the coming years. Personalized medicine is a healthcare approach that customizes treatments based on an individual's genetic, environmental, and lifestyle factors, leading to more precise and effective therapies. The growing interest in personalized medicine can be attributed to advancements in genomic technologies, which allow treatments to be tailored to a person's genetic profile. This approach significantly enhances the management of ADHD by enabling customized treatment strategies that address an individual's unique characteristics, leading to more targeted and effective interventions. For example, in February 2024, a report from the Personalized Medicine Coalition revealed that personalized medicines accounted for over a third of new FDA drug approvals in 2023, marking the fourth consecutive year. The FDA approved 16 new personalized treatments for rare diseases, 7 cancer drugs, and 3 other treatments. As a result, the growing adoption of personalized medicine is driving the expansion of the ADHD market.

Companies in the ADHD market are focusing on developing innovative treatments such as extended-release tablets to improve efficacy, enhance patient compliance, and provide long-lasting symptom control. These tablets release medication gradually, providing consistent control of symptoms throughout the day with a single dose. This reduces the need for multiple doses, improving convenience and adherence to the treatment plan for individuals with ADHD. For instance, in February 2022, JAMP Pharma Group, a pharmaceutical company based in Canada, launched Guanfacine XR, a generic version of Takeda Canada Inc.'s INTUNIV XR. Guanfacine XR is a long-acting medication that targets receptors in the brain to improve attention, impulse control, and hyperactivity. Available in various strengths (1 mg, 2 mg, 3 mg, and 4 mg) and packaged in 100-count bottles, the drug offers flexibility in treatment.

In September 2024, Collegium Pharmaceutical Inc., a US-based specialty pharmaceutical company, acquired Ironshore Therapeutics Inc. for $525 million. This acquisition is part of Collegium's strategy to expand its portfolio beyond pain management and strengthen its presence in the growing ADHD market, particularly with its differentiated ADHD product, Jornay PM. Ironshore Therapeutics, also based in the US, focuses on developing and commercializing therapies for ADHD.

Major players in the attention deficit hyperactivity disorder market are Pfizer Inc., Johnson & Johnson, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Supernus Pharmaceuticals Inc., Neos Therapeutics Inc., Collegium Pharmaceutical Inc., Mallinckrodt Pharmaceuticals plc, Tris Pharma Inc., Arbor Pharmaceuticals LLC, Akili Interactive Labs Inc., Mind Medicine (MindMed) Inc., NeuroSigma Inc., KemPharm Inc., RespireRx Pharmaceuticals Inc., Cingulate Therapeutics LLC, and Adlon Therapeutics L.P.

North America was the largest region in the attention deficit hyperactivity disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in attention deficit hyperactivity disorder report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the attention deficit hyperactivity disorder market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The attention deficit hyperactivity disorder market consists of revenues earned by entities by providing services such as diagnosis, therapy, counselling, medication management, and digital health solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The attention deficit hyperactivity disorder (ADHD) market also includes sales of medical devices, digital therapeutics, and assistive learning tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Attention Deficit Hyperactivity Disorder Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on attention deficit hyperactivity disorder market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for attention deficit hyperactivity disorder ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The attention deficit hyperactivity disorder market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Stimulants; Non-Stimulants
2) By Age Group: Children; Adults
3) By Gender: Male; Female
4) By Dosage Form: Tablets; Capsules; Other Dosage Forms
5) By Distribution Channel: Retail Pharmacy; Hospital Pharmacy; Online Pharmacy
Subsegments:
1) By Stimulants: Methylphenidate-based Medications; Amphetamine-based Medications; Mixed Amphetamine Salts; Dexmethylphenidate
2) By Non-Stimulants: Atomoxetine (Strattera); Guanfacine (Intuniv); Clonidine (Kapvay); Bupropion (Wellbutrin)
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AstraZeneca PLC; Novartis International AG; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.; Otsuka Pharmaceutical Co. Ltd.; Supernus Pharmaceuticals Inc.; Neos Therapeutics Inc.; Collegium Pharmaceutical Inc.; Mallinckrodt Pharmaceuticals plc; Tris Pharma Inc.; Arbor Pharmaceuticals LLC; Akili Interactive Labs Inc.; Mind Medicine (MindMed) Inc.; NeuroSigma Inc.; KemPharm Inc.; RespireRx Pharmaceuticals Inc.; Cingulate Therapeutics LLC; Adlon Therapeutics L.P.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r33974u

1. Executive Summary

2. Attention Deficit Hyperactivity Disorder Market Characteristics

3. Attention Deficit Hyperactivity Disorder Market Trends And Strategies

4. Attention Deficit Hyperactivity Disorder Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Attention Deficit Hyperactivity Disorder Growth Analysis And Strategic Analysis Framework

5.1. Global Attention Deficit Hyperactivity Disorder PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Attention Deficit Hyperactivity Disorder Market Growth Rate Analysis
5.4. Global Attention Deficit Hyperactivity Disorder Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Attention Deficit Hyperactivity Disorder Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Attention Deficit Hyperactivity Disorder Total Addressable Market (TAM)

6. Attention Deficit Hyperactivity Disorder Market Segmentation

6.1. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Stimulants
Non-Stimulants
6.2. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Children
Adults
6.3. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Male
Female
6.4. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Other Dosage Forms
6.5. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retail Pharmacy
Hospital Pharmacy
Online Pharmacy
6.6. Global Attention Deficit Hyperactivity Disorder Market, Sub-Segmentation Of Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Methylphenidate-based Medications
Amphetamine-based Medications
Mixed Amphetamine Salts
Dexmethylphenidate
6.7. Global Attention Deficit Hyperactivity Disorder Market, Sub-Segmentation Of Non-Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Atomoxetine (Strattera)
Guanfacine (Intuniv)
Clonidine (Kapvay)
Bupropion (Wellbutrin)

7. Attention Deficit Hyperactivity Disorder Market Regional And Country Analysis

7.1. Global Attention Deficit Hyperactivity Disorder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Attention Deficit Hyperactivity Disorder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Attention Deficit Hyperactivity Disorder Market

8.1. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Attention Deficit Hyperactivity Disorder Market

9.1. China Attention Deficit Hyperactivity Disorder Market Overview
9.2. China Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Attention Deficit Hyperactivity Disorder Market

10.1. India Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Attention Deficit Hyperactivity Disorder Market

11.1. Japan Attention Deficit Hyperactivity Disorder Market Overview
11.2. Japan Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Attention Deficit Hyperactivity Disorder Market

12.1. Australia Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Attention Deficit Hyperactivity Disorder Market

13.1. Indonesia Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Attention Deficit Hyperactivity Disorder Market

14.1. South Korea Attention Deficit Hyperactivity Disorder Market Overview
14.2. South Korea Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Attention Deficit Hyperactivity Disorder Market

15.1. Western Europe Attention Deficit Hyperactivity Disorder Market Overview
15.2. Western Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Attention Deficit Hyperactivity Disorder Market

16.1. UK Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Attention Deficit Hyperactivity Disorder Market

17.1. Germany Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Attention Deficit Hyperactivity Disorder Market

18.1. France Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Attention Deficit Hyperactivity Disorder Market

19.1. Italy Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Attention Deficit Hyperactivity Disorder Market

20.1. Spain Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Attention Deficit Hyperactivity Disorder Market

21.1. Eastern Europe Attention Deficit Hyperactivity Disorder Market Overview
21.2. Eastern Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Attention Deficit Hyperactivity Disorder Market

22.1. Russia Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Attention Deficit Hyperactivity Disorder Market

23.1. North America Attention Deficit Hyperactivity Disorder Market Overview
23.2. North America Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Attention Deficit Hyperactivity Disorder Market

24.1. USA Attention Deficit Hyperactivity Disorder Market Overview
24.2. USA Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Attention Deficit Hyperactivity Disorder Market

25.1. Canada Attention Deficit Hyperactivity Disorder Market Overview
25.2. Canada Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Attention Deficit Hyperactivity Disorder Market

26.1. South America Attention Deficit Hyperactivity Disorder Market Overview
26.2. South America Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Attention Deficit Hyperactivity Disorder Market

27.1. Brazil Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Attention Deficit Hyperactivity Disorder Market

28.1. Middle East Attention Deficit Hyperactivity Disorder Market Overview
28.2. Middle East Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Attention Deficit Hyperactivity Disorder Market

29.1. Africa Attention Deficit Hyperactivity Disorder Market Overview
29.2. Africa Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Attention Deficit Hyperactivity Disorder Market Competitive Landscape And Company Profiles

30.1. Attention Deficit Hyperactivity Disorder Market Competitive Landscape
30.2. Attention Deficit Hyperactivity Disorder Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Attention Deficit Hyperactivity Disorder Market Other Major And Innovative Companies

31.1. Eli Lilly and Company
31.2. Teva Pharmaceutical Industries Ltd.
31.3. Otsuka Pharmaceutical Co. Ltd.
31.4. Supernus Pharmaceuticals Inc.
31.5. Neos Therapeutics Inc.
31.6. Collegium Pharmaceutical Inc.
31.7. Mallinckrodt Pharmaceuticals plc
31.8. Tris Pharma Inc.
31.9. Arbor Pharmaceuticals LLC
31.10. Akili Interactive Labs Inc.
31.11. Mind Medicine (MindMed) Inc.
31.12. NeuroSigma Inc.
31.13. KemPharm Inc.
31.14. RespireRx Pharmaceuticals Inc.
31.15. Cingulate Therapeutics LLC

32. Global Attention Deficit Hyperactivity Disorder Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Attention Deficit Hyperactivity Disorder Market

34. Recent Developments In The Attention Deficit Hyperactivity Disorder Market

35. Attention Deficit Hyperactivity Disorder Market High Potential Countries, Segments and Strategies

35.1 Attention Deficit Hyperactivity Disorder Market In 2029 - Countries Offering Most New Opportunities
35.2 Attention Deficit Hyperactivity Disorder Market In 2029 - Segments Offering Most New Opportunities
35.3 Attention Deficit Hyperactivity Disorder Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer